Michael W Harr Selected Research

Bronchogenic Carcinoma

6/2007	The interactive transcript abundance index [c-mycp73alpha]/[p21Bcl-2] correlates with baseline level of apoptosis and response to CPT-11 in human bronchogenic carcinoma cell lines.
1/2006	Stable low-level expression of p21WAF1/CIP1 in A549 human bronchogenic carcinoma cell line-derived clones down-regulates E2F1 mRNA and restores cell proliferation control.
7/2005	Variation in transcriptional regulation of cyclin dependent kinase inhibitor p21waf1/cip1 among human bronchogenic carcinomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael W Harr Research Topics

Disease

3	Neoplasms (Cancer) 02/2011 - 08/2003
3	Bronchogenic Carcinoma 06/2007 - 07/2005
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 03/2011
1	Lymphoma (Lymphomas) 03/2011
1	Leukemia 03/2011
1	Lung Neoplasms (Lung Cancer) 08/2003

Drug/Important Bio-Agent (IBA)

1	Peptides (Polypeptides)IBA 03/2011
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 02/2011
1	Irinotecan (Camptosar)FDA LinkGeneric 06/2007
1	Messenger RNA (mRNA)IBA 01/2006
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 07/2005
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 08/2003
1	Complementary DNA (cDNA)IBA 08/2003

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 06/2007